- Home
- EVMN vs IIIV Comparison
EVMN vs IIIV Comparison
Compare EVMN & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | IIIV |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 565.5M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | EVMN | IIIV |
|---|---|---|
| Price | $21.90 | $23.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $39.33 | $33.33 |
| AVG Volume (30 Days) | 92.4K | ★ 298.2K |
| Earning Date | 01-01-0001 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | $3,000,000.00 | ★ $213,158,000.00 |
| Revenue This Year | N/A | $9.74 |
| Revenue Next Year | N/A | $8.09 |
| P/E Ratio | ★ N/A | $164.93 |
| Revenue Growth | ★ 40.00 | 11.47 |
| 52 Week Low | $16.70 | $22.00 |
| 52 Week High | $24.03 | $33.97 |
Technical Indicators
Market Signals| Indicator | EVMN | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 25.59 |
| Support Level | N/A | $22.57 |
| Resistance Level | N/A | $24.14 |
| Average True Range (ATR) | 0.00 | 1.32 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 0.00 | 14.17 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About IIIV i3 Verticals Inc.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.